Neuroendocrine alterations in lung cancer patients

Gianluigi Mazzoccoli, Stefano Carughi, Angelo De Cata, Marco La Viola, Antonio Giuliani, Roberto Tarquini, Federico Perfetto

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: A number of qualitative and quantitative changes in hormonal secretion pattern have been found in subjects suffering from neoplastic disease. The aim of this study was to evaluate the presence of alterations in neuro-endocrine system function and in the pattern of endocrine secretion in patients with lung cancer. Methods: Cortisol, melatonin, growth hormone (GH), insulin-like growth factor I (IGF-I), thyrotropin-releasing hormone (TRH), thyroid-stimulating-hormone (TSH), and free thyroxine (FT 4) serum levels were measured on blood samples collected every four hours for 24 hours from ten healthy old subjects aged 65-79 years (mean age±s.e. 67.28±3.11) and from ten subjects suffering from untreated non small cell lung cancer aged 65-78 years (mean age±s.e. 68.57±1.81). Areas under the curve and mean diurnal and nocturnal levels were compared and the presence of circadian rhythmicity was evaluated. Results: When hormone levels were expressed as area under the curve GH levels were higher (p=0.004) and IGF-I levels were lower (p=0.006) in patients with lung cancer than in normal subjects. The evaluation of melatonin/cortisol ratio in all subjects showed a significant difference between the control group and the group of cancer patients (p

Original languageEnglish
Pages (from-to)77-82
Number of pages6
JournalNeuroendocrinology Letters
Volume24
Issue number1-2
Publication statusPublished - Feb 2003

Fingerprint

Lung Neoplasms
Melatonin
Insulin-Like Growth Factor I
Growth Hormone
Area Under Curve
Hydrocortisone
Endocrine System
Thyrotropin-Releasing Hormone
Periodicity
Thyrotropin
Thyroxine
Non-Small Cell Lung Carcinoma
Healthy Volunteers
Hormones
Control Groups
Serum
Neoplasms

Keywords

  • Cortisol
  • FT4
  • GH
  • IGF-I
  • Lung cancer
  • Melatonin
  • Neuro-endocrine system
  • TRH
  • TSH

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Mazzoccoli, G., Carughi, S., De Cata, A., La Viola, M., Giuliani, A., Tarquini, R., & Perfetto, F. (2003). Neuroendocrine alterations in lung cancer patients. Neuroendocrinology Letters, 24(1-2), 77-82.

Neuroendocrine alterations in lung cancer patients. / Mazzoccoli, Gianluigi; Carughi, Stefano; De Cata, Angelo; La Viola, Marco; Giuliani, Antonio; Tarquini, Roberto; Perfetto, Federico.

In: Neuroendocrinology Letters, Vol. 24, No. 1-2, 02.2003, p. 77-82.

Research output: Contribution to journalArticle

Mazzoccoli, G, Carughi, S, De Cata, A, La Viola, M, Giuliani, A, Tarquini, R & Perfetto, F 2003, 'Neuroendocrine alterations in lung cancer patients', Neuroendocrinology Letters, vol. 24, no. 1-2, pp. 77-82.
Mazzoccoli G, Carughi S, De Cata A, La Viola M, Giuliani A, Tarquini R et al. Neuroendocrine alterations in lung cancer patients. Neuroendocrinology Letters. 2003 Feb;24(1-2):77-82.
Mazzoccoli, Gianluigi ; Carughi, Stefano ; De Cata, Angelo ; La Viola, Marco ; Giuliani, Antonio ; Tarquini, Roberto ; Perfetto, Federico. / Neuroendocrine alterations in lung cancer patients. In: Neuroendocrinology Letters. 2003 ; Vol. 24, No. 1-2. pp. 77-82.
@article{91434638888242eabb67a18b2434ca34,
title = "Neuroendocrine alterations in lung cancer patients",
abstract = "Background: A number of qualitative and quantitative changes in hormonal secretion pattern have been found in subjects suffering from neoplastic disease. The aim of this study was to evaluate the presence of alterations in neuro-endocrine system function and in the pattern of endocrine secretion in patients with lung cancer. Methods: Cortisol, melatonin, growth hormone (GH), insulin-like growth factor I (IGF-I), thyrotropin-releasing hormone (TRH), thyroid-stimulating-hormone (TSH), and free thyroxine (FT 4) serum levels were measured on blood samples collected every four hours for 24 hours from ten healthy old subjects aged 65-79 years (mean age±s.e. 67.28±3.11) and from ten subjects suffering from untreated non small cell lung cancer aged 65-78 years (mean age±s.e. 68.57±1.81). Areas under the curve and mean diurnal and nocturnal levels were compared and the presence of circadian rhythmicity was evaluated. Results: When hormone levels were expressed as area under the curve GH levels were higher (p=0.004) and IGF-I levels were lower (p=0.006) in patients with lung cancer than in normal subjects. The evaluation of melatonin/cortisol ratio in all subjects showed a significant difference between the control group and the group of cancer patients (p",
keywords = "Cortisol, FT4, GH, IGF-I, Lung cancer, Melatonin, Neuro-endocrine system, TRH, TSH",
author = "Gianluigi Mazzoccoli and Stefano Carughi and {De Cata}, Angelo and {La Viola}, Marco and Antonio Giuliani and Roberto Tarquini and Federico Perfetto",
year = "2003",
month = "2",
language = "English",
volume = "24",
pages = "77--82",
journal = "Neuroendocrinology Letters",
issn = "0172-780X",
publisher = "Maghira and Maas Publications",
number = "1-2",

}

TY - JOUR

T1 - Neuroendocrine alterations in lung cancer patients

AU - Mazzoccoli, Gianluigi

AU - Carughi, Stefano

AU - De Cata, Angelo

AU - La Viola, Marco

AU - Giuliani, Antonio

AU - Tarquini, Roberto

AU - Perfetto, Federico

PY - 2003/2

Y1 - 2003/2

N2 - Background: A number of qualitative and quantitative changes in hormonal secretion pattern have been found in subjects suffering from neoplastic disease. The aim of this study was to evaluate the presence of alterations in neuro-endocrine system function and in the pattern of endocrine secretion in patients with lung cancer. Methods: Cortisol, melatonin, growth hormone (GH), insulin-like growth factor I (IGF-I), thyrotropin-releasing hormone (TRH), thyroid-stimulating-hormone (TSH), and free thyroxine (FT 4) serum levels were measured on blood samples collected every four hours for 24 hours from ten healthy old subjects aged 65-79 years (mean age±s.e. 67.28±3.11) and from ten subjects suffering from untreated non small cell lung cancer aged 65-78 years (mean age±s.e. 68.57±1.81). Areas under the curve and mean diurnal and nocturnal levels were compared and the presence of circadian rhythmicity was evaluated. Results: When hormone levels were expressed as area under the curve GH levels were higher (p=0.004) and IGF-I levels were lower (p=0.006) in patients with lung cancer than in normal subjects. The evaluation of melatonin/cortisol ratio in all subjects showed a significant difference between the control group and the group of cancer patients (p

AB - Background: A number of qualitative and quantitative changes in hormonal secretion pattern have been found in subjects suffering from neoplastic disease. The aim of this study was to evaluate the presence of alterations in neuro-endocrine system function and in the pattern of endocrine secretion in patients with lung cancer. Methods: Cortisol, melatonin, growth hormone (GH), insulin-like growth factor I (IGF-I), thyrotropin-releasing hormone (TRH), thyroid-stimulating-hormone (TSH), and free thyroxine (FT 4) serum levels were measured on blood samples collected every four hours for 24 hours from ten healthy old subjects aged 65-79 years (mean age±s.e. 67.28±3.11) and from ten subjects suffering from untreated non small cell lung cancer aged 65-78 years (mean age±s.e. 68.57±1.81). Areas under the curve and mean diurnal and nocturnal levels were compared and the presence of circadian rhythmicity was evaluated. Results: When hormone levels were expressed as area under the curve GH levels were higher (p=0.004) and IGF-I levels were lower (p=0.006) in patients with lung cancer than in normal subjects. The evaluation of melatonin/cortisol ratio in all subjects showed a significant difference between the control group and the group of cancer patients (p

KW - Cortisol

KW - FT4

KW - GH

KW - IGF-I

KW - Lung cancer

KW - Melatonin

KW - Neuro-endocrine system

KW - TRH

KW - TSH

UR - http://www.scopus.com/inward/record.url?scp=0038218549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038218549&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 77

EP - 82

JO - Neuroendocrinology Letters

JF - Neuroendocrinology Letters

SN - 0172-780X

IS - 1-2

ER -